Brain surgery gets a High-Tech helper: first human test of CIPHER system begins
NCT ID NCT07465796
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tests a new device called the CIPHER System, which records brain activity during surgery to remove a type of brain tumor called glioma. Ten adults with newly diagnosed glioma will have the device placed on their brain surface during standard tumor removal. The main goals are to check if the device is safe and if it can record brain signals properly. This is a data-gathering study, not a treatment trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CIPHER System (electrocorticography probe)
What this could lead to
If successful, this could lead to better tools for surgeons to identify tumor boundaries during brain surgery.
What could go wrong
This is a very early, small study (10 people) focused on safety and data collection, not treatment. The device may not improve outcomes or could cause side effects like seizures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Royal Melbourne Hospital, Department of Neurosurgery 4 East
RECRUITINGMelbourne, Victoria, 3050, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact